Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Classifica tra le azioni #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Prezzo delle azioni
$1.50
Ultima sincronizzazione: 2026-09-21
Capitalizzazione di mercato
$3.63M
Variazione (1 giorno)
-4.46%
Variazione (1 anno)
-72.68%
Paese
MY
Scambia BioNexus Gene Lab Corp. (BGLC)

Categoria

Rapporto P/S per BioNexus Gene Lab Corp. (BGLC)
Rapporto P/S al September 2026 TTM: 1.16
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di BioNexus Gene Lab Corp., il rapporto P/S attuale (TTM) è 1.16. Alla fine del 2023, era pari a 0.93.
Storico del rapporto P/S per BioNexus Gene Lab Corp. da 2016 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
2026 (TTM) 1.16 123.02%
2024 0.52 -43.84%
2023 0.93 -93.79%
2022 15.03 -44.95%
2021 27.30 37.30%
2020 19.89 -98.67%
2019 1.50K 117.75%
2018 687.59 -54.92%
2017 1.53K 0.00%
2016 0.00 0.00%
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
3.20 175.99%
US
6.48 459.13%
US
- -
US
0.66 -43.43%
US
- -
US